21CC Cancer Intelligence (Issue 47): Reindeer Bio/Xinda Bio BCMA Targeted CAR-T Therapy Approved for Market Launch; The latest phase 3 test results of AstraZeneca HIMALAYA are positive
21CC(cancercare)2121CC//BCMACAR-T630NMPABBCMACAR-TMM3BCMACAR-TCT103AIBI326BCMACAR-TTCARscFvCD8a4-1BBCD3NMPAFDA/20232FDA/NMPA20226628NMPArepotrectinibROS1Rafael AmadoROS15CDEROS16281ALKNSCLCWX-0593ALK/ROS1ALKALKROS1WX-0593ALKROS1NSCLC180mgIIALK1469.390412056IRCORR67...
Tech >>
2023-07-03 22:16:40